| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
33,580,000 |
| Market
Cap: |
85.96(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.738 - $3.54 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 12.5 |
| Insider 6 Months : 12.5 |
| Insider 3/6 Months : 24.9 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Rezolute is a clinical-stage biopharmaceutical company developing therapies for metabolic diseases related to chronic glucose imbalance. Co.'s primary clinical asset, RZ358, is a potential treatment for congenital hyperinsulinism, a pediatric genetic disorder characterized by excessive production of insulin by the pancreas. Co.'s second clinical asset, RZ402, is an oral plasma kallikrein inhibitor being developed as a potential therapy for the chronic treatment of diabetic macular edema.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
188,903 |
188,903 |
193,903 |
3,432,245 |
| Total Buy Value |
$319,782 |
$319,782 |
$329,282 |
$12,634,145 |
| Total People Bought |
4 |
4 |
4 |
5 |
| Total Buy Transactions |
13 |
13 |
14 |
19 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Handok, Inc. |
10% Owner |
– – • |
2020-07-28 |
4 |
AB |
$0.32 |
$40,575 |
D/D |
125,000 |
94,089,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-27 |
4 |
AB |
$0.34 |
$42,188 |
D/D |
125,000 |
93,964,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-24 |
4 |
AB |
$0.31 |
$39,313 |
D/D |
125,000 |
93,839,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-23 |
4 |
AB |
$0.30 |
$56,511 |
D/D |
187,000 |
93,714,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-22 |
4 |
AB |
$0.28 |
$70,750 |
D/D |
250,000 |
93,527,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-21 |
4 |
AB |
$0.25 |
$63,150 |
D/D |
250,000 |
93,277,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-20 |
4 |
AB |
$0.26 |
$65,650 |
D/D |
250,000 |
93,027,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-17 |
4 |
AB |
$0.21 |
$52,175 |
D/D |
250,000 |
92,777,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-16 |
4 |
AB |
$0.19 |
$46,650 |
D/D |
250,000 |
92,527,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-15 |
4 |
AB |
$0.16 |
$39,350 |
D/D |
250,000 |
92,277,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-14 |
4 |
AB |
$0.16 |
$13,205 |
D/D |
84,000 |
92,027,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-13 |
4 |
AB |
$0.15 |
$15,290 |
D/D |
100,000 |
91,943,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-10 |
4 |
AB |
$0.13 |
$2,412 |
D/D |
18,550 |
91,843,587 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-09 |
4 |
AB |
$0.13 |
$17,341 |
D/D |
133,804 |
91,825,037 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-08 |
4 |
AB |
$0.12 |
$5,460 |
D/D |
45,200 |
91,691,233 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-07 |
4 |
AB |
$0.11 |
$4,745 |
D/D |
45,100 |
91,646,033 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2020-07-06 |
4 |
AB |
$0.10 |
$30,360 |
D/D |
300,000 |
91,600,933 |
|
- |
|
| Genexine Inc. |
10% Owner |
– – • |
2019-07-23 |
4 |
B |
$0.29 |
$10,000,000 |
D/D |
34,482,758 |
91,300,933 |
2.45 |
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2019-07-23 |
4 |
B |
$0.29 |
$10,000,000 |
D/D |
34,482,758 |
91,300,933 |
2.45 |
- |
|
| Genexine Inc. |
10% Owner |
– – • |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
56,818,175 |
56,818,175 |
|
- |
|
| Handok, Inc. |
10% Owner |
– – • |
2019-04-26 |
4 |
A |
$0.00 |
$0 |
D/D |
56,818,175 |
56,818,175 |
|
- |
|
| Kim Young-Jin |
Director |
– • – |
2019-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,250,000 |
|
- |
|
| Sung Young Chul |
Director |
– • – |
2019-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,250,000 |
|
- |
|
| Welch David F |
Director |
– • – |
2017-03-06 |
4 |
B |
$0.95 |
$4,750 |
I/I |
5,000 |
1,796,415 |
2.1 |
- |
|
| Welch David F |
Director |
– • – |
2017-02-10 |
4 |
B |
$0.99 |
$4,950 |
I/I |
5,000 |
28,100 |
2.1 |
- |
|
113 Records found
|
|
Page 4 of 5 |
|
|
0.09 (3.4%) 
